-
Targeting lipid and energy metabolism for cardiovascular diseases
이은우 한국생명공학연구원 대사제어연구센터 12:00~12:20 -
Next generation NAD⁺ therapeutics via new modalities
류동렬 GIST 의생명공학과 12:20~12:40 -
Development of cardiovascular therapeutics through regulation of endothelial dysfunction
장우철 부산대 생물교육과 12:40~13:00 - Panel Discussion 13:00~13:20
-
Precision nutrition through continuous glucose monitoring: decoding postprandial glycemic responses for cardiometabolic health
박다현 고려대 보건과학대학 12:00~12:20 -
AI-based food drug interaction and clinical application in cardiometabolic diseases
김모건 한국외대 바이오메디컬공학부 12:20~12:40 -
Nutritional management as a GLP-1 adjuvant: bridging pharmacotherapy and dietary intervention for metabolic health
신민정 고려대 바이오시스템의과학부 12:40~13:00 - Panel Discussion 13:00~13:20
-
Decoding lipoprotein(a): genetics and measurement insights
이장훈 경북의대 순환기내과 12:00~12:16 -
Lipoprotein(a) epidemiology: Western and Korean data
장영우 가천의대 심장내과 12:16~12:32 -
Unveiling the clinical impact of lipoprotein(a)
주형준 고려의대 순환기내과 12:32~12:48 -
Lipoprotein(a) as the next frontier in cardiovascular therapy
위진 가천의대 심장내과 12:48~13:04 - Panel Discussion 13:04~13:20
-
Genetic and mechanistic insights into triglyceride-rich lipoproteins and cardiometabolic disease
김병진 성균관의대 순환기내과 13:50~14:08 -
Omega-3 fatty acids: from triglyceride reduction to cardiovascular outcomes
임수 서울의대 내분비대사내과 14:08~14:26 -
APOC3 metabolism and therapeutic approaches
김남훈 고려의대 내분비내과 14:26~14:44 -
ANGPTL3/4/8 inhibition: translational insights and clinical development
정혜문 경희의대 심장내과 14:44~15:02 - Panel Discussion 15:02~15:20
-
CVD risk prediction in lipid guidelines
김은지 가천의대 예방의학과 13:50~14:08 -
CVD risk prediction in diabetes guidelines
구유정 서울의대 내분비내과 14:08~14:26 -
CVD risk prediction in hypertension guidelines
천대영 한림의대 순환기내과 14:26~14:44 -
CVD risk prediction in the context of CKM health
이호규 연세의대 예방의학과 14:44~15:02 - Panel Discussion 15:02~15:20
-
How should we apply the 2025 dyslipidemia guidelines in real-world Korean practice?
윤종찬 가톨릭의대 순환기내과 15:20~15:40 -
Early and intensive lipid-Lowering after acute coronary syndrome: timing, targets, and real-world challenges
임수빈 이화의대 순환기내과 15:40~16:00 -
Managing residual atherosclerotic risk: beyond LDL-C toward precision lipid therapy
이수연 단국의대 심장혈관내과 16:00~16:20 - Panel Discussion 16:20~16:50
-
Bempedoic acid: a non-statin option for LDL-C lowering
차정준 고려의대 순환기내과 08:30~08:48 -
The evolving landscape of PCSK9 inhibitors: siRNA, oral agents, and mAbs
안준호 전남의대 순환기내과 08:48~09:06 -
Lp(a)-lowering therapies: olpasiran and other emerging agents
최성훈 한림의대 순환기내과 09:06~09:24 -
CETP inhibitors: revisiting an old target with new molecules
홍준화 을지의대 내분비내과 09:24~09:42 - Panel Discussion 09:42~10:00
-
Updated risk stratification and treatment pathways in the 2026 Korean guidelines
정재훈 동국의대 심장내과 13:10~13:28 -
Optimizing pharmacologic therapy in the 2026 Korean guidelines
오진경 충남의대 심장내과 13:28~13:46 -
Lifestyle interventions in dyslipidemia care: evidence updates and practical recommendations for Korea
조가람 고려대 보건과학대학 13:46~14:04 -
Managing dyslipidemia in special population in the 2026 Korean guidelines
장영우 가천의대 심장내과 14:04~14:22 - Panel Discussion 14:22~14:40
-
Association between cumulative LDL-C exposure during young adulthood and middle age and risk of cardiovascular events
양여리 가톨릭의대 내분비내과 13:10~13:28 -
TBD
TBD TBD 13:28~13:46 -
MASLD as a cardiovascular risk enhancer in primary prevention
김경수 차의대 내분비내과 13:46~14:04 -
Effects of statins for primary prevention in the elderly: recent evidence
이상학 연세의대 심장내과 14:04~14:22 - Panel Discussion 14:22~14:40
-
Coronary artery calcium and imaging-based risk assessment in clinical practice
TBD TBD 13:10~13:30 -
Assessment of arterial remodeling and atherosclerosis progression using carotid ultrasound
이종영 한림의대 순환기내과 13:30~13:50 -
Pulse wave velocity and ankle-brachial index as indicators of arterial health
권오성 가톨릭의대 순환기내과 13:50~14:10 - Panel Discussion 14:10~14:40
-
From basic discovery to clinical translation: macrophage-targeted imaging and therapy for high-risk plaque
김진원 고려의대 순환기내과 15:30~15:50 -
Intracellular Ca²⁺ dysregulation links lipotoxicity to defective autophagy
오병철 가천의대 생리학교실 15:50~16:10 -
In vitro modeling of atherosclerosis using iPSC-derived blood vessel organoids
김다현 성신여대 바이오생명공학과 16:10~16:30 - Panel Discussion 16:30~17:00
-
Sex differences in metabolic syndrome and heart
박성미 고려의대 순환기내과 15:30~15:50 -
Uncovering FPR2 as a determinant of sex differences in liver fibrosis
정영미 부산대 생명과학과 15:50~16:10 -
Sex-dependent microbe-metabolite interactions in cardiometabolic diseases
유현주 서울대 식품영양학과 16:10~16:30 - Panel Discussion 16:30~17:00
-
The role of early PCSK-9 inhibitor in patients with ACS
조윤경 계명의대 심장내과 15:30~15:48 -
Lp(a) and atherosclerotic burden: new targets in the post-PCI era
우종신 경희의대 심장내과 15:48~16:06 -
The association between coronary artery plaque and ANGPTL4
한정규 서울의대 순환기내과 16:06~16:24 -
Inflammation and atherosclerosis: recent advances in anti-inflammatory therapy
김병식 한양의대 심장내과 16:24~16:42 - Panel Discussion 16:42~17:00